Why pharma firms are betting billions on psychedelic drugs despite setbacks

2026-10-27来源 Nature NewsEnglish

Nature, Published online: 27 October 2026; doi:10.1038/d41586-026-03390-8

Regulatory pushback stalled the field. But researchers are optimistic about mind-altering drugs as potential treatments for depression and mood disorders.

原文：https://www.a8q9.cn/en/article/why-pharma-firms-are-betting-billions-on-psychedelic-drugs-despite-setbacks-4fb5d7.html

相关文章